NewsTosser

Alzheimer's Focused on Wrong Target: Angry Microglia Are Real Problem

Aug 26, 2026 •Wellness

Drug corporations have poured billions into a twenty-year quest for an Alzheimer's magic pill that could truly stop this terrible disease. Most of those efforts failed because researchers kept looking at the wrong target entirely. I explained last week in my new book, Brain Defenders, why that approach misses the mark completely. We are told repeatedly to focus on removing sticky beta-amyloid plaques from the brain tissue, but that is not the real problem waiting inside our skulls.

The key issue lies with how specialized immune cells called microglia behave within the brain and spinal cord. These guards normally sit in a calm M2 state where they clean up dead cells and fight off infections to keep brain tissue healthy for years. However, factors like aging, infection, or a poor diet can trigger them into an aggressive M1 state through gut inflammation that travels upward. Once transformed, these angry microglia attack nerve cells and synapses while also creating those very plaques we are told to fear.

There is hope on the horizon because lifestyle changes like regular exercise and eating high-fibre foods with low ultra-processed items can positively influence this system. Even better, new evidence shows that certain medications already available for other conditions might optimize microglia function as well. We see drugs used for diabetes treatment such as metformin, plus immunomodulators that control immune responses to prevent organ rejection in transplants, and even some antidepressants all showing promise here. By using supplements strategically, you can fill nutritional gaps and give your brain's defense cells an extra edge against decline.

Dr David Perlmutter is a US neurologist who recommends specific medications designed to optimize microglia activity for better brain health. Much of this research remains in its early stages right now, yet it highlights intense focus on microglial optimization as a promising avenue for future Alzheimer's prevention and treatment methods. Aside from these powerful medications, common dietary supplements can also drive healthier microglia activity inside the human body if taken correctly. Please remember that no amount of pills will fix poor diets which are strongly linked to dangerous microglia activation in older adults.

Nor am I suggesting you take clinical medication for anything other than what your doctor has prescribed. But as a neurologist with over 40 years of experience treating Alzheimer's and other neurodegenerative diseases, I feel truly encouraged by the potential these drugs and supplements hold against the disease. Here is my look at the most promising medications being researched alongside the range of supplements you might consider to safeguard your brain function. The goal is protecting your microglia.

Metformin first gained prominence in the 1950s as a treatment for type 2 diabetes. It was initially thought to work by reducing glucose production in the liver. Further research has revealed it turbo-charges our mitochondria, those tiny energy powerhouses inside cells that help keep microglia in the supportive M2 state. Metformin also boosts insulin sensitivity to stop glucose levels from building up in the blood. This helps reduce microglial overactivation and aids cognitive enhancement. Studies show a link between metformin and a reduced risk of dementia. A 2024 study published in Clinical Diabetes and Endocrinology supports this view. In the US, nationwide clinical trials at 14 leading research institutions involving 3,000 people aged 65 to 79 are expected soon. The trial will last six years and is called Targeting Aging with Metformin or TAME. It explores metformin's potential as an anti-ageing drug, including its impact on Alzheimer's. I believe the findings likely show metformin as a prime candidate for preventing age-related cognitive decline.

Without question, GLP-1 agonist drugs like Ozempic represent the biggest pharmaceutical game changer recently. Beyond reducing appetite, their ability to change the shape and function of microglial cells is nothing short of miraculous. A 2023 study in the International Journal of Medical Sciences showed GLP-1s directly bind to microglia and reduce activation. This decreases the release of damaging pro-inflammatory cytokines, which act as chemical messengers that cause inflammation in the brain known as neuroinflammation. Neuroinflammation is linked to Alzheimer's because it triggers the creation of M1 microglia. There is also evidence these drugs increase levels of BDNF, a protein acting like fertilizer for our neurons. A notable 2024 study published in Alzheimer's & Dementia analysed medical records of more than one million patients with type 2 diabetes. It revealed those treated with Ozempic had a significantly lower risk of being diagnosed with Alzheimer's compared to others on different diabetes medications. Further supporting these findings, a clinical trial led by Imperial College London in 2024 investigated the effects of liraglutide, brand name Saxenda, on patients already diagnosed with mild Alzheimer's. Participants receiving daily liraglutide injections for more than a year exhibited 18 per cent less cognitive decline and a 50 per cent reduction in brain cell loss compared to the placebo group. These results indicate GLP-1 drugs may slow neurodegeneration in Alzheimer's patients.

All this said, we must remember GLP-1 is an impressive hormone produced naturally in our body. Dietary changes such as eating high-fibre foods can promote healthy GLP-1 levels without medication. Reducing sweeteners and added sugars helps too. Avoiding ultra-processed foods makes a difference as well.

If GLP-1s get officially proven to work on diseases like Alzheimer's or Parkinson's, then I am fully behind their clinical use. That would be a game changer.

Minocycline is an antibiotic people already know and use. It has drawn attention lately because of its ability to fight inflammation. Recent findings show it stops microglia from activating in ways that cause damage. A 2024 study on mice from China found the drug protected these brain cells from shifting into their harmful M1 form. This happened even when the animals faced a strong inflammatory trigger, such as lipopolysaccharide. Researchers use that compound to spark inflammation in labs all the time.

Dimethyl fumarate is another option. It is an oral medicine approved for multiple sclerosis under the brand name Tecfidera. The drug works by turning on the NRF2 signaling pathway inside the brain. When this system goes active, it kicks into gear against toxins and cuts down inflammation. It also helps regulate the immune response by targeting M1 microglia specifically. This approach helps patients with MS, but it could assist those with Alzheimer's as well.

You can also use supplements to fill nutritional gaps and give your microglia an extra boost. Always talk to a healthcare professional first, especially if you have existing health issues or take other medications. Here are a few key supplements worth looking at. You will find fifteen more in my book.

Omega 3 fatty acids deserve a spot on this list. The most useful form is docosahexaenoic acid, or DHA. It is an essential fat that makes up as much as 20 percent of the brain's total fat content. DHA serves as a major building block for neuronal membranes and improves communication between cells. It also fights chronic neuroinflammation by supporting microglia function. Plus, it raises levels of BDNF. Low BDNF links to higher Alzheimer's risk. This might explain how DHA guards against age-related thinking problems, according to a 2017 mouse study in Scientific Reports. Experts suggest taking between 1,000 and 2,000 mg of DHA daily for top brain health. Cod liver oil is the best supplement source. Vegetarians can turn to algae-based versions instead. Wild-caught fish like salmon, sardines, and mackerel offer great dietary options too. Surprisingly, farmed Atlantic salmon sometimes contains more DHA than wild varieties. A 100g serving of farmed salmon might have around 1,700 mg. Free range eggs hold between 100 and 150 mg per egg.

Creatine deserves a mention as well. It shuttles energy to places where the brain needs it most, such as synapses. It also strengthens mitochondria, which helps keep microglia in their supportive M2 state. A pilot study from 2025 at the University of Kansas Medical Center gave 19 Alzheimer's patients 20g of creatine daily for eight weeks. Tests showed statistically significant gains in cognitive ability among participants. Larger studies with proper controls are needed, but this research offers promising early signs. Improving the brain's energy production machinery could hold real promise in the fight against Alzheimer's disease.

The recommended daily intake sits around five grams, pushing the absolute ceiling to ten grams for most people. Those suffering from kidney disease or currently taking nephrotoxic drugs must speak with a doctor first. This warning applies specifically to certain cancer treatments, antibiotics, and immunosuppressants that can damage kidney function.

Magnesium stands out as a mineral supporting hundreds of biochemical reactions throughout the body. It aids nerve and muscle function while promoting relaxation and reducing stress levels. These effects indirectly benefit microglia by enhancing mitochondrial performance. While several types exist on the market, magnesium threonate is often considered best for cognition because it contains L-threonic acid. This compound helps transport magnesium from the gut directly into the brain. You can find this mineral in leafy greens, nuts, and wholegrains without buying a supplement. Aim for between 200 and 400mg daily unless you have kidney disease, are pregnant, or suffer from heart conditions, in which case medical advice is necessary.

The link between the gut microbiome and the brain cannot be overstated. A deficient collection of bacteria has been proven to trigger inflammatory symptoms inside your brain that affect microglia directly. Taking a high-quality probiotic makes logical sense given this connection. Seek out a product containing a wide array of different strains with a colony forming unit count of at least 50 billion to ensure live bacteria content is sufficient. Some individuals experience mild bloating or gas initially, but these symptoms generally resolve with continued use over time.

MitoQ10 represents a synthetic version of the antioxidant coenzyme Q10 that your body produces naturally. It was designed specifically to protect mitochondria from damage. Early studies suggest it can reduce neuron death associated with Alzheimer's disease. The standard dosage is 10mg per day, though nausea remains a possible side-effect. Always check with your doctor before taking this supplement if you are pregnant or suffer from kidney, liver, or heart issues.

Sprouted Himalayan tartary buckwheat has rapidly gained attention as a true superfood thanks to its rich polyphenol content. These compounds act as powerful antioxidants that support mitochondrial health. A pilot study published in Frontiers of Nutrition in 2024 found participants taking a polyphenol-rich supplement derived from Tartary buckwheat for ninety days showed significant improvements in epigenetic age markers and immune cell profiles. These are the tiny changes within your body that turn genes on and off. Just one teaspoon daily is the suggested amount. Be aware that polyphenols may interact with statins, certain antidepressants, and immunosuppressant medications so caution is advised.

This guidance comes from Brain Defenders by David Perlmutter, set for publication in August 27 via Yellow Kite. The book carries a price tag of £18.99 but ordering through mailshop.co.uk/books drops the cost to £17.09 if you act before the offer expires on 31/08/26. Customers spending over £25 get free UK postage and packaging. You can also call 020 3176 2937 to place an order directly.

braindementiadiethealthmedication